Email Newsletters

Life Sciences

Sanofi Completes Genzyme Stock Offer

French drug maker Sanofi-Aventis has completed its exchange offer for Genzyme Corp. stock, leaving it with control...

Genzyme CEO To Be FSU Speaker

Henri Termeer, chairman and CEO of Genzyme Corp., will be the undergraduate commencement speaker at Framingham State...

RXi Buys Biotech Firm, Gets New CEO

RXi Pharmaceuticals, the Worcester-based development-stage drug company, has purchased an Arizona company and replaced its president and...

Generex To Spin Off Worcester Co.

Antigen Express of Worcester will become its own publicly traded company under a planned reorganization of Generex...
ADVERTISEMENT

More Genzyme Supply Trouble

New manufacturing problems at Genzyme Corp.'s Allston Landing plant may mean patients will miss doses of the...

Two Worcester Firms Get Life Sciences Loans

The Massachusetts Life Sciences Center awarded $3.75 million in loans to five biotech companies today, including two...

ACT Gets Chinese Patent

 Advanced Cell Technology in Marlborough has received patent protection in China for a...

ACT Revenues Down, Losses Up

Revenues for Advanced Cell Technology of Marlborough fell to $725,044 in 2010, from $1.4 million in 2009...
ADVERTISEMENT

Biotech Co. Leases Marlborough Space

Biotechnology firm Ipsen-Biomeasure has leased 10,565 square feet of lab space in Marlborough, according to O'Brien Commercial...

UMass Stem Cell Bank To Work With UK Partner

Officials at the University of Massachusetts Stem Cell Bank and Registry in Shrewsbury will explore collaborations with...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA